Status:
TERMINATED
Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer
Lead Sponsor:
Centre Georges Francois Leclerc
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study evaluates the dose received by the prostate with in vivo dosimetry when delivering image guided radiation therapy (IGRT) associated with intensity modulated radiation therapy (IMRT) for pat...
Detailed Description
10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective is to evaluate...
Eligibility Criteria
Inclusion
- male \> 18 years
- carcinoma of the prostate histologically confirmed
- OMS 0-1
- localized stage
- favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification
- patients must have signed a written informed consent form
- patients must be affiliated to a Social Health Insurance.
Exclusion
- metastasis
- indication for pelvic radiation
- anticoagulant therapy
- lateral or bilateral hip replacement
- patient receiving an adult protective services
- Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons
Key Trial Info
Start Date :
December 22 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 6 2019
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT02279693
Start Date
December 22 2014
End Date
August 6 2019
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Georges-François Leclerc
Dijon, France, 21000